SODIUM SUCCINATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Succinate, and what generic alternatives are available?
Sodium Succinate is a drug marketed by Elkins Sinn and is included in one NDA.
The generic ingredient in SODIUM SUCCINATE is sodium succinate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium succinate profile page.
Summary for SODIUM SUCCINATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 35 |
Patent Applications: | 1,260 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM SUCCINATE at DailyMed |
Recent Clinical Trials for SODIUM SUCCINATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
HagaZiekenhuis | Phase 3 |
Leiden University Medical Center | Phase 3 |
Maastricht University Medical Center | Phase 3 |
US Patents and Regulatory Information for SODIUM SUCCINATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Elkins Sinn | SODIUM SUCCINATE | sodium succinate | INJECTABLE;INJECTION | 080516-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |